Molecularly targeted therapies for p53-mutant cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecularly targeted therapies for p53-mutant cancers

Published:2017-06-22 Issue:22 Volume:74 Page:4171-4187
ISSN:1420-682X
Container-title:Cellular and Molecular Life Sciences
language:en
Short-container-title:Cell. Mol. Life Sci.

Author:

Zhao Dekuang,Tahaney William M.,Mazumdar Abhijit,Savage Michelle I.,Brown Powel H.

Funder

Susan G. Komen for the Cure

Breast Cancer Research Foundation

John Charles Cain Distinguished Chair Award

National Cancer Institute (US) Cancer Center Support Grant

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Cellular and Molecular Neuroscience,Pharmacology,Molecular Biology,Molecular Medicine

Link

http://link.springer.com/article/10.1007/s00018-017-2575-0/fulltext.html

Reference161 articles.

1. Brown CJ, Lain S, Verma CS, Fersht AR, Lane DP (2009) Awakening guardian angels: drugging the p53 pathway. Nat Rev Cancer 9(12):862–873

2. Mandinova A, Lee SW (2011) The p53 pathway as a target in cancer therapeutics: obstacles and promise. Sci Transl Med 3(64):64rv1

3. Reinhardt HC, Schumacher B (2012) The p53 network: cellular and systemic DNA damage responses in aging and cancer. Trends Genet 28(3):128–136

4. Pellegata NS, Antoniono RJ, Redpath JL, Stanbridge EJ (1996) DNA damage and p53-mediated cell cycle arrest: a reevaluation. Proc Natl Acad Sci USA. 93(26):15209–15214

5. Hainaut P, Wiman KG (2009) 30 years and a long way into p53 research. Lancet Oncol. 10(9):913–919

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced pharmacological activities of AKR1C3‐activated prodrug AST‐3424 in cancer cells with defective DNA repair;International Journal of Cancer;2024-09-07

2. Current and Emerging Diagnostic, Prognostic, and Predictive Biomarkers in Head and Neck Cancer;Biomedicines;2024-02-10

3. Exploring Potentilla nepalensis Phytoconstituents: Integrated Strategies of Network Pharmacology, Molecular Docking, Dynamic Simulations, and MMGBSA Analysis for Cancer Therapeutic Targets Discovery;Pharmaceuticals;2024-01-19

4. The influence of a modified p53 C-terminal peptide by using a tumor-targeting sequence on cellular apoptosis and tumor treatment;Apoptosis;2023-12-25

5. Potentilla nepalensis leaf extract revealed p53, Nf-kB1, and HSP proteins as biomarkers – Network Pharmacology, Molecular Docking and Dynamic studies;2023-11-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3